Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Soleno Therapeutics (SLNO – Research Report) and ...

10 analysts have shared their evaluations of Rhythm Pharmaceuticals (NASDAQ:RYTM) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

H.C. Wainwright raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $70 from $69 and keeps a Buy rating on the shares following the Q4 report. The firm believes the company’s ...

In 2021, Starbucks celebrated a significant milestone: its 40th anniversary. To mark this occasion, the coffee giant unveiled a bold new logo that refreshed its iconic image while honouring its rich ...

Rhythm Pharmaceuticals had a negative net margin of 230.07% and a negative return on equity of 367.36%. The company had revenue of $41.83 million during the quarter, compared to analyst estimates ...

Citizens JMP reiterated its Market Outperform rating on Rhythm Pharmaceuticals (NASDAQ:RYTM) with a steady price target of $81.00, well above current trading levels of... On Wednesday, Raymond ...